REQUEST A DEMO
Total
USD $0.00
FAQ
Secure shopping

Pharma & Healthcare

The Pharma & Healthcare industry is of vital importance for human and economic development, providing a wide range of goods and services relevant to the promotion of health at all stages in the healthcare process – from prevention and treatment to rehabilitation and palliative care. It is one of the fastest-growing industries, supported by profound demographic changes, the rising incidence of non-communicable diseases, and surging per capita health spending in both developed and emerging markets. The industry is also one of the major innovators, with increasing expenditures on development of new molecules, biotechnology and adoption of new technologies that provide advanced healthcare and ensure the longevity of the population.

The Pharma & Healthcare industry comprises the manufacture of pharmaceuticals for human and veterinary use, medical equipment and related supplies. It also includes providers of ambulatory health services, medical and diagnostic laboratories, hospitals, and nursing and residential care facilities.

1 2 3 4 5 7
Indonesia Pharma and Healthcare Sector Report 2020-2021 - Page 1
Indonesia Pharma and Healthcare Sector Report 2020-2021 EMIS Insights Industry Reports

Indonesia has one of the fastest-growing pharmaceuticals and healthcare sectors in the ASEAN region, in large part due to the government’s active role in encouraging development. Still, Indonesia’s healthcare services provision is ...

View more details
USD 495 Date: April 2020 Language: English
Format: PDF
Add to basket
Latin America Pharma and Healthcare Sector Report 2019/2023 - Page 1
Latin America Pharma and Healthcare Sector Report 2019/2023 EMIS Insights Industry Reports

In the past two decades, Latin America has embraced a universal health strategy, based on the principles of equity, solidarity and collective action. This strategy required steadily growing public expenditure on health in order to guarantee universal ...

View more details
USD 495 Date: April 2020 Language: English
Format: PDF
Add to basket
Brazil Pharma and Healthcare Sector 2019/2023  - Page 1
Brazil Pharma and Healthcare Sector 2019/2023 EMIS Insights Industry Reports

Due to a growing and ageing population, and an increasing incidence of non-communicable diseases, Brazil became the seventh largest pharmaceutical market in the world in 2018. During the year, retail drug sales, based on pharmacy purchase price (PPP) ...

View more details
USD 995 Date: March 2020 Language: English
Format: PDF
Add to basket
Mexico Pharma and Healthcare Sector 2020/2021 - Page 1
Mexico Pharma and Healthcare Sector 2020/2021 EMIS Insights Industry Reports

Mexico is the second largest pharmaceutical market in Latin America, behind only Brazil, with retail drug sales of USD 10.2bn in 2018. The country also features a growing and ageing population, multiple but underfunded state-run health insurance ...

View more details
USD 495 Date: March 2020 Language: English
Format: PDF
Add to basket
China Healthcare Sector Report 2019 4th Quarter - Page 1
China Healthcare Sector Report 2019 4th Quarter EMIS Insights Industry Reports

In Q3 2019 China’s healthcare sector continued to expand, stimulated by further structural reforms. The period saw increased government spending on healthcare, with expenditure on health and family planning growing by 12.1% y/y to RMB 369.3bn. ...

View more details
USD 495 Date: February 2020 Language: English
Format: PDF
Add to basket
Emerging Europe Pharma and Healthcare Sector Report 2019/2023 - Page 1
Emerging Europe Pharma and Healthcare Sector Report 2019/2023 EMIS Insights Industry Reports

Although quite different in terms of political and economic systems, the Emerging Europe countries share certain similarities when it comes to their demographic situation and health profile. With the exception of Turkey, whose average birth rate is ...

View more details
USD 495 Date: February 2020 Language: English
Format: PDF
Add to basket
Chile Pharma and Healthcare Sector Report 2020/2021 - Page 1
Chile Pharma and Healthcare Sector Report 2020/2021 EMIS Insights Industry Reports

In a Latin American context, Chile is not a particularly large pharmaceutical and healthcare market, since its population is relatively small and healthy in terms of the incidence of communicable diseases. However, the country’s changing ...

View more details
USD 495 Date: February 2020 Language: English
Format: PDF
Add to basket
Argentina Pharma and Healthcare Sector 2019/2020 - Page 1
Argentina Pharma and Healthcare Sector 2019/2020 EMIS Insights Industry Reports

In 2018, Argentina was the third largest pharmaceutical market in Latin America with retail drug sales of USD 4.9bn. The country has a large and ageing population, a relatively developed public health system, and a small but consolidated private ...

View more details
USD 495 Date: February 2020 Language: English
Format: PDF
Add to basket
Malaysia Pharma and Healthcare Sector Report 2019/2020 - Page 1
Malaysia Pharma and Healthcare Sector Report 2019/2020 EMIS Insights Industry Reports

Malaysia has one of the most developed pharmaceuticals and healthcare sectors in the ASEAN region. The country operates a dual public-private healthcare system in which the government, under the Ministry of Health (“MoH”), both regulates ...

View more details
USD 495 Date: January 2020 Language: English
Format: PDF
Add to basket
China Healthcare Sector Report 2019 3rd Quarter - Page 1
China Healthcare Sector Report 2019 3rd Quarter EMIS Insights Industry Reports

China’s healthcare sector kept growing over the second quarter of 2019. The period was characterised by increased government spending on healthcare, with the amount dedicated to health and family planning rising by 5.9% y/y to RMB 534.5bn in Q2 ...

View more details
USD 495 Date: November 2019 Language: English
Format: PDF
Add to basket
1 2 3 4 5 7